FAMILIES of teens who have fallen prey to ketamine have told of the horror of watching their kids turn into “zombies” in ...
ScienceAlert on MSN
This week in science: Reversing Alzheimer's, solving a tapestry mystery, and more!
A promising Alzheimer's breakthrough as an experimental drug completely reverses mental decline in mice with advanced disease ...
US FDA accepts Axsome Therapeutics’ supplemental New Drug Application for AXS-05 to treat Alzheimer’s disease agitation: New York Saturday, January 3, 2026, 12:00 Hrs [IST] Ax ...
Morning Overview on MSN
Scientists repair Alzheimer’s damage in mice instead of just slowing it
For decades, Alzheimer’s disease has been framed as a one‑way slide, with treatments aiming only to slow the descent. Now a ...
Axsome stock jumps as the FDA grants priority review to sNDA for AXS-05 in Alzheimer's agitation, with a decision expected April 30, 2026.
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback